Home
 /
Papers
 /
Genetics
 /
Non-disruptive 3D profiling of combinations of epigenetic marks in single cells
Preprint
Open access
V1
Top 1% · Validated by QED

Non-disruptive 3D profiling of combinations of epigenetic marks in single cells

Yanbo Chen, Jonathan S.D. Radda, Myles H. Alderman +6 more
June 2025
 ·
bioRxiv
 ·
DOI 
10.1101/2025.06.13.659535
94
%
Reproducible
QED Impressions
This paper passed independent validation.
QED's automated review checked the evidence supporting each claim, the statistical methods, and whether the results are reproducible from the data provided.

It ranks in the top 1% of preprints assessed in Genetics this quarter.
Run full QED analysis
Read paper
Save

Why this is interesting

By preserving 3D genome architecture while profiling multiple epigenetic marks at hundreds of loci in single cells, Epi-PHR unlocks allele-resolved spatial epigenomics—exposing unexpected H3K9me3-driven chromatin boundaries at imprinted loci impossible to detect before.

QED claims analysis

Summary

Epigenetic Proximity Hybridization Reaction (Epi-PHR) enables non-disruptive, locus-specific detection of single and combinatorial epigenetic marks at hundreds of genomic loci in individual cells while preserving three-dimensional chromatin architecture, revealing that H3K9me3 abundance positively correlates with chromatin domain boundary formation at the maternally imprinted Meg3 locus through allele-specific multi-omic profiling that integrates epigenetic state with chromatin conformation.

See full analysis
Main Claim 1 –

Epi-PHR Enables Locus-Specific In Situ Epigenetic Detection Preserving 3D Genome

Supporting evidence

  • Epi-PHR Detects Epigenetic Marks at 2-kb Genomic Targets
  • Epi-PHR Preserves 3D Architecture for Combined Chromatin Tracing Analysis
  • Epi-PHR Preserves Chromatin Architecture Whereas Epigenomic MERFISH Disrupts It
Main Claim 2 –

Epi-PHR Profiles Hundreds of Loci with ChIP-seq Concordance

Supporting evidence

  • Tissue Dual-Mark Epi-PHR Maps Region-Specific Single-Gene Epigenetic States
  • Epi-PHR Outperforms Epigenomic MERFISH for Repressive Mark Profiling
Main Claim 3 –

Dual-Mark Epi-PHR Co-profiles Two Epigenetic Marks at Hundreds of Loci

Main Claim 4 –

Phased Epi-PHR Links Allele-Specific Marks with Chromatin Conformation

Abstract

Recent advancements in single-cell sequencing and spatial omics technologies have enhanced our understanding of diverse cellular identities, compositions, architectures, and functions. However, the single-cell three-dimensional (3D) organization of the epigenome is still not well understood, due to an absence of spatial single-cell methods that allow high-resolution, locus-specific detection of combinations of epigenetic marks while maintaining the 3D organization of the genome. Here, we develop Epigenetic Proximity Hybridization Reaction (Epi-PHR), a non-disruptive image-based single-cell spatial epigenetic profiling technology. Epi-PHR enables locus-specific and high-resolution in situ detection of combinations of epigenetic marks at hundreds of single gene targets within the same individual cells, while retaining the 3D organization of the genome. Dual-mark Epi-PHR in hippocampus tissue sections revealed region-specific epigenetic profiles. Phased Epi-PHR combined with chromatin tracing simultaneously detects allele-specific epigenetic states and chromatin conformations of a paternally imprinted Meg3 gene cluster in single cells, revealing associations between specific epigenetic mark enrichment and chromatin folding features for the distinct alleles from different parental origins. Surprisingly, we found that H3K9me3 abundance is positively associated with a chromatin domain boundary at the Meg3 locus among maternal copies. We expect Epi-PHR will be broadly applicable in research requiring single-cell spatial epigenetic information, and will help extend our understanding of the combinatorial epigenetic code and its relationship with chromatin organization.

Related papers

How the QED Score works

QED Score is a validated AI-based quality metric that evaluates life science papers on two dimensions: originality and validity. Each manuscript is anonymized, broken down into its claims and supporting evidence, and examined by specialized AI agents for statistical rigor, consistency across figures, and fit with the existing literature. Scores are percentile ranks, so they're comparable across fields. In blinded tests, expert professors sided with QED Score over journal rank in 75% of decisive cases.
Read the methodology

Free access for academic researchers

Create your free QED account to validate your research, strengthen grant proposals, and uncover scientific insights.
We've sent you an access link.
Please check your inbox.

Didn't get your email? Check your spam folder or reach out to info@qedscience.com

Oops! Something went wrong while submitting the form.
Looking for QED for pharma, biotech or life science organizations?